This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,396.20 firm fixed-price delivery order is for the supply of QNASL 80 MCG nasal spray. The contract has an ultimate completion date of December 10, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.
This contract award was not designated with any set-aside requirements, indicating open competition. The agency's focus on supporting military treatment facilities, veterans' healthcare programs, and other federal medical institutions through comprehensive pharmaceutical and medical supply contracts is evident.
Generated 3/10/25, 9:48 AM